\n <\/p>\n
Revealed on Apr 24, 2026<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n Observe us on X @investorideas @stocknewsbites<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
\n
\n Share
\n <\/a>
\n<\/section><\/div>\n
\n
<\/p>\n
\n
\n <\/figure>\n
\n
<\/p>\n
\n (Investorideas.com<\/a>
\n Newswire) a go-to platform for giant investing concepts, together with biotech
\n and medical tech inventory points a information and buying and selling alert for Scinai
\n Immunotherapeutics Ltd. (NASDAQ: SCNI<\/a>).
\n <\/p>\n
\n
<\/p>\n
\n Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI<\/a>) makes the Nasdaq prime gainers record in the present day, at the moment buying and selling at
\n 0.8867 +0.4307 (+94.45%) on a quantity of 162 million shares as of
\n this report.\u00a0
\n <\/p>\n
\n It seems like retail merchants and promotions are pushing the inventory
\n following information .
\n <\/p>\n
\n Scinai Immunotherapeutics in the present day introduced that it has entered right into a
\n securities buy settlement with an institutional life sciences
\n investor, in addition to with new and current institutional and
\n accredited traders, for the acquisition and sale of 5,208,333
\n American Depositary Shares (ADSs), every representing 4,000 peculiar
\n shares, at a purchase order value of $0.48 per ADS, in addition to a Sequence A
\n warrant to buy as much as 5,208,333 ADSs at an train value of
\n $0.48 per ADS, exercisable instantly with a time period of two years, and
\n a Sequence B warrant to buy as much as 5,208,333 ADSs at an train
\n value of $0.55 per ADS, exercisable instantly with a time period of 5
\n years.
\n <\/p>\n
\n Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI<\/a>) is a biopharmaceutical firm centered on the event of
\n progressive immunology therapies. The corporate is advancing a pipeline
\n of therapeutic candidates licensed from the Max Planck Society and
\n from PinCell S.r.l.
\n <\/p>\n
\n Scinai additionally owns Scinai Biopharma Providers Ltd., a contract
\n growth and manufacturing group (CDMO), offering
\n growth and manufacturing providers to biotechnology and
\n pharmaceutical firms. www.scinai.com
\n <\/p>\n
\n Full Information<\/a>
\n <\/p>\n<\/p><\/div>\n
\n <\/article>\n
\n
<\/p>\n
\n Analysis biotech shares at Investorideas.com\u00a0<\/strong>
\n <\/p>\n
\n https:\/\/www.investorideas.com\/BIS\/stock_list.asp<\/a>
\n <\/p>\n
\n Be a part of the Investorideas telegram dialogue about biotech shares\u00a0
\n <\/p>\n
\n https:\/\/www.investorideas.com\/membership\/<\/a>
\n <\/p>\n
\n About Investorideas.com \u2013 The place you discover the most effective investing
\n concepts\u00a0<\/strong>
\n <\/p>\n
\n Investorideas.com<\/a>\u00a0is the go-to platform for giant investing concepts. From breaking
\n inventory information to top-rated investing podcasts, we cowl all of it. Our
\n unique branded content material consists of podcasts corresponding to Exploring Mining,
\n Cleantech, Crypto Nook, Hashish Information, and the AI Eye. We additionally create
\n free investor inventory directories for sectors together with mining, crypto,
\n renewable power, gaming, biotech, tech, sports activities and extra. Public
\n firms inside the sectors we cowl can use our information publishing and
\n content material creation providers to assist inform their story to
\n traders. Paid content material is all the time disclosed.
\n <\/p>\n
\n Disclaimer\/Disclosure Our web site doesn’t make suggestions for
\n purchases or sale of shares, providers or merchandise. Nothing on our websites
\n ought to be construed as a proposal or solicitation to purchase or promote merchandise
\n or securities. All investing entails threat and doable losses. This
\n web site is at the moment compensated for information publication and distribution,
\n social media and advertising and marketing, content material creation and extra. Disclosure is
\n posted for every compensated information launch, content material printed\/created if
\n required however in any other case the information was not compensated for and was
\n printed for the only curiosity of our readers and followers. Contact
\n administration and IR of every firm instantly relating to particular questions.
\n Extra disclaimer data: Extra
\n disclaimer<\/a>
\n and
\n disclosure<\/a>
\n data
\n https:\/\/www.investorideas.com\/About\/Disclaimer.asp<\/a>\u00a0 World traders should adhere to laws of every nation.
\n Please learn Investorideas.com privateness coverage:\u00a0https:\/\/www.investorideas.com\/About\/Private_Policy.asp<\/a>
\n <\/p>\n
\n Be taught extra about our information, PR and social media, podcast providers at
\n Investorideas.com for AI shares\u00a0<\/strong>
\n <\/p>\n
\n https:\/\/www.investorideas.com\/Buyers\/Providers.asp<\/a>
\n <\/p>\n
\n Be taught extra about digital promoting and visitor posts for AI<\/strong>
\n <\/p>\n
\n https:\/\/www.investorideas.com\/Promote\/<\/a>
\n <\/p>\n
\n Observe us on Fb
\n https:\/\/www.fb.com\/Investorideas<\/a>
\n <\/p>\n
\n Observe us on YouTube
\n https:\/\/www.youtube.com\/c\/Investorideas<\/a>
\n <\/p>\n
\n Join free inventory information alerts at Investorideas.com\u00a0
\n <\/p>\n
\n https:\/\/www.investorideas.com\/Sources\/E-newsletter.asp<\/a>
\n <\/p>\n
\n Disclaimer\/Disclosure:<\/strong> Investorideas.com is a digital
\n writer of third celebration sourced information, articles and fairness analysis as
\n properly as creates unique content material, together with video, interviews and
\n articles. Unique content material created by investorideas is protected by
\n copyright legal guidelines aside from syndication rights. Our web site doesn’t make
\n suggestions for purchases or sale of shares, providers or merchandise.
\n Nothing on our websites ought to be construed as a proposal or solicitation to
\n purchase or promote merchandise or securities. All funding entails threat and
\n doable lack of funding. This web site is at the moment compensated for information
\n publication and distribution, social media and advertising and marketing, content material
\n creation and extra. Contact every firm instantly relating to content material and
\n press launch questions.. Extra disclaimer data:
\n http:\/\/www.investorideas.com\/About\/Disclaimer.asp<\/a>. This text is a 3rd celebration visitor submit printed content material and never
\n the content material of Investorideas.com . Be taught extra about posting your
\n articles at
\n http:\/\/www.investorideas.com\/Promote\/<\/a>
\n <\/p>\n